NSCLC Coverage From Every Angle

Ongoing CE Activities

Advanced Non-Small Cell Lung Ccancer Patient Management Simulator
Advanced NSCLC: What Would You Do?
An Advanced Practitioner’s Guide to Cell Signaling Pathways in NSCLC
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care-Lung Cancer: Advanced Disease
ASTRO Issues New Guidelines on Stereotactic Radiation in Early NSCLC
Biomarker Analysis and the Implications for the Treatment of Non-Small Cell Lung Cancer
Case Studies in ALK-Translocated Advanced NSCLC: From Diagnosis to Treatment
Checkpoint Inhibitors in First-Line Advanced NSCLC: What Should You Know?
Clinical Challenges and Best Practices in Managing ALK-Positive NSCLC
Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer
Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Non-Small Cell Lung Cancer
Effects of Early Integrated Palliative Care on Caregivers of Patients with Lung and Gastrointestinal Cancer: A Randomized Clinical Trial
EGFR-Mutated NSCLC and CNS Involvement: The Conundrum
EXPERT EXCHANGE: Management of Advanced EGFR Mutation-Positive NSCLC: Making Bold Strides Toward True Precision Medicine
For Pulmonologists by Pulmonologists: Diagnosis of NSCLC in an Age of Biomarkers
Reflecting on Recent Evidence With an Eye to the Future of Lung Cancer Management
Immunotherapy in Advanced NSCLC: Will Combination Therapies Become Standard?
Integrating Targeted Strategies in NSCLC
Integration of Immunotherapies Into the Treatment of Patients With Non–Small Cell Lung Cancer
JADPRO Regional Lectures: Immunotherapy: Case Studies in Non-Small Cell Lung Cancer
Lung Cancer series
Lung Cancer Update, Issue 2, 2017
Management of Advanced NSCLC: Where Do Immune Checkpoint Inhibitors Fit In?:
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
NCCN Continuing Education in Lung Cancer
NCCN Launches NCCN Congress Webinar Series™: Biomarkers 101
Oncology Grand Rounds Series: Part 1 — Non-Small Cell Lung Cancer: A satellite symposium held at the 2017 ONS Annual Congress
One of These Is Not Like the Other: Pathology Reports in Advanced NSCLC
Optimizing Outcomes in Advanced NSCLC
Outcomes in NSCLC: A Focus on Quality Improvement - Part 1
Outcomes in NSCLC: A Focus on Quality Improvement - Part 2
Sustaining Change in Quality Improvement for NSCLC – Part 3
The Emerging Role of Molecular Testing in an Era of Precision Medicine - Non–Small Cell Lung Cancer
Treatment of EGFR-Mutated NSCLC: Assessing Your Clinical Practice
Year in Review: Proceedings from the Multitumor Regional Symposium Focused on the Application of Emerging Research Information to the Care of Patients with Common Cancers